Evidence map›Paper›PMID 32472969›Full record

Trial reportPediatric blood & cancer2020

Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphoma.

Hiroto Inaba, Olga Varechtchouk, Michael D Neel, Matthew J Ehrhardt, Monika L Metzger, Seth E Karol, Kirsten K Ness, Raul C Ribeiro, Ching-Hon Pui, Mary V Relling and 2 more

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hiroto InabaDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-0605-7342
Olga VarechtchoukDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Michael D NeelDepartment of Surgery, St Jude Children's Research Hospital, Memphis, Tennessee.
Matthew J EhrhardtDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Monika L MetzgerDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Seth E KarolDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-8113-8180
Kirsten K NessDepartment of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-2084-1507
Raul C RibeiroDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Ching-Hon PuiDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-0303-5658
Mary V RellingDepartment of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-3720-9591
John T SandlundDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Sue C KasteDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
St. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS CA21765NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

backgroundOsteonecrosis is a debilitating complication in children and adolescents with acute lymphoblastic leukemia or acute lymphoblastic lymphoma (LLy). An objective screening test to identify patients at risk for symptomatic, extensive joint involvement will help manage osteonecrosis.

methodsWe performed a prospective, longitudinal pilot study with whole-joint magnetic resonance imaging (MRI) of shoulders, elbows, hips, knees, ankles, and hindfeet to evaluate the incidence and timing of osteonecrosis involving multiple joints in 15 patients with LLy aged 9-21 years at diagnosis.

resultsOsteonecrosis affecting ≥30% of the epiphysis occurred in eight of 15 patients, with a high prevalence in hips (12 of 26 examined [46%]) and knees (10 of 26 [38%]) post reinduction I and in shoulders (seven of 20 [35%]) post reinduction II. Most osteonecrotic hips and knees with ≥30% epiphyseal involvement became symptomatic and/or underwent surgery (100% and 82%, respectively). All eight patients with ≥30% epiphyseal involvement had multijoint involvement. Seven of these patients had hip or knee osteonecrosis by the end of remission induction, and only these patients developed osteonecrosis that became symptomatic and/or underwent surgery in their hips, knees, shoulders, ankles, and/or feet; all of these joints were associated with epiphyseal abnormalities on post reinduction I imaging.

conclusionsMRI screening in adolescent patients with LLy revealed osteonecrosis in multiple joints. Initial screening with hip and knee MRI at the end of induction may identify susceptible patients who could benefit from referrals to subspecialties, more extensive follow-up imaging of other joints, and early medical and surgical interventions.

Indexed as

Magnetic Resonance ImagingOsteonecrosisPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentChildFemaleHumansIncidenceJointsMaleRisk Factorsacute lymphoblastic lymphomamagnetic resonance imagingosteonecrosispediatricswhole joints

Identifiers

PMID32472969
PMCPMC7391358
OpenAlexW3029501424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.